Novartis Reaffirms FY2026 Outlook; Net Sales to Grow Low Single-Digit, Core Operating Income to Decline Low Single-Digit

Benzinga Newsdesk www.benzinga.com Negative 85.0%

Neg 85% Neu 0% Pos 0%

Full year 2026 guidance2 reaffirmed

o Net sales expected to grow low single-digit and core operating income expected to decline low single-digit

Comments

No comments yet. Be the first!